Camptocormia in patients with multiple system atrophy with different disease durations
Objective: The aims of this study were to explore the prevalence of and factors associated with camptocormia in a cohort of multiple system atrophy (MSA)…Higher grey matter aging in multiple system atrophy than Parkinson’s disease
Objective: To investigate the “brain age” signature in multiple system atrophy (MSA) and Parkinson's disease (PD), and its correlation with motor and cognitive performance. Background:…Morphology and Signal Changes of the Lentiform Nucleus Based on Susceptibility Weighted Imaging in Parkinsonism predominant Multiple System Atrophy
Objective: This present case-control study was aimed to investigate both morphological and signal intensity changes in susceptibility weighted imaging(SWI) of the Lentiform Nucleus (LN) for…Bilateral vocal cord paralysis associated with idiopathic Parkinson’s disease
Objective: We present two cases of bilateral vocal cord paralysis (BVCP) associated with idiopathic Parkinson’s disease (iPD). Background: BVCP is a rare complication associated with…To compare early / late onset MSA from the PAN American MSA (PANMSA) database
Objective: Compare two different cohorts of patients with the same pathology differentiated by age of onset. Background: Multiple system atrophy (MSA) is a rare neurodegenerative…Multiple System Atrophy: phenotypic spectrum approach coupled with brain FDG PET
Objective: This study attempts to identify different phenotypes of patients with MSA and to describe corresponding brain 18-FDG Positron Emission Tomography (PET) patterns. Background: In…Availability of levodopa and clinicopathological features of patients with multiple system atrophy
Objective: To investigate the availability of levodopa for pathologically confirmed multiple system atrophy (MSA) patients and determine the clinicopathological features of levodopa responders with MSA.…Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA
Objective: To complete the baseline analysis of clinical data from the PROSPECT-M-UK study and to assess the impact of applying current MDS PSP diagnostic criteria…Differential Value of Brain Magnetic Resonance Imaging in MSA-C and SCAs
Objective: Diagnostic value of brain magnetic resonance imaging (MRI) in differentiating multiple system atrophy cerebellar (MSA-C) phenotype and spinocerebellar ataxias (SCAs) was assessed according to…[18F] FDG-PET findings associated with cognitive impairment if multiple system atrophy
Objective: To explore the cortical metabolic pattern associated with cognitive impairment in multiple system atrophy (MSA). Background: Cognitive impairment (CI) has been increasingly recognized in…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 20
- Next Page »